Hospital death Hospital death
Variable
Frequency n (%)
Prevalence n (%)
PR (CI 95%)
p
Genre 0.119
Male 237(59,70) 117(63.93) 1.20(0.95-1.50)
Feminine 160(40,30) 66(36.07) 1
Age 0.000
20-59 167(42,07) 57(31.15) 1
60 or more 230(57,93) 126(68.85) 1.61(1.26-2.04)
Systemic arterial hypertension 0.228
No 184(46.46) 91(49.45) 1
Yes 212(53.54) 92(43.40) 1.139(0.85-1.52)
Diabetes mellitus 0.082
No 275(69,27) 64(34.97) 1
Yes 122(30,73) 119(65.03) 1.21(0.98-1.50)
Hypothyroidism 0.800
No 374(94,21) 173(94,54) 1,06(0,66-1,72)
Yes 23(5,79) 10(5,46) 1
Hyperthyroidism 0,000
No 396(99,75) 182(99,45) 0,46(0,41-0,51)
Yes 1(0,25) 1(0,55) 1
Chronic obstructive pulmonary disease 0,622
No 363(91,44) 166(90,71) 0,91(0,64-1,30)
Yes 34(8,56) 17(9,29) 1
Cardiovascular disease 0,546
No 356(89,67) 166(90,71) 1,12(0,77-1,64)
Yes 41(10,33) 17(9,29) 1
Cerebrovascular disease 0,595
No 377(94,96) 175(95,63) 1,16(0,67-2,00)
Yes 20(5,04) 8(4,37) 1
Mental health related illness 0,185
No 384(96,73) 175(95,63) 0,74(0,47-1,15)
Yes 13(3,27) 8(4,37) 1
Thrombosis history -
Não 396(99,75) 183(100,00) -
Sim 1(0,25) 0(0,00) -
Hepatitis A 0,469
No 392(98,74) 180(98,36) 1,31(0,63- 2,69)
Yes 5(1,26) 3(1,64) 1
Hepatitis B 0,469
No 392(98,74 180(98,36) 1,31(0,63-2,70)
Yes 5(1,26) 3(1,64) 1
Hepatitis C 0,469
No 392(98,74) 180(98,36) 1,31(0,63-2,70)
Yes 5(1,26) 3(1,64) 1
Asthma 0,000
No 391(98,49) 179(97,81) 0,46(0,41-0,51)
Yes (treating) 1(0,25) 1(0,55) 1
Yes (cured) 5(1,26) 3(1,64) 0,59(0,29-1,23)
Liver failure 0,000
No 390(98,24) 178(97,27) 0,46(0,41-0,51)
Yes (treating) 1(0,25) 1(0,55) 1
Yes (cured) 6(1,51) 4(2,19) 0,66(0,38-1,17)
Smoking 0,002
No 369(92,95) 167(91,26) 0,61(0,46-0,82)
Yes (smoker) 9(2,27) 2(1,09) 0,30(0,09-1,06)
Yes (already smoked) 19(4,79) 14(7,65) 1
Alcohol consumption 0,397
No 345(86,90) 162(88,52) 1,16(0,82-1,65)
Yes 52(13,10) 21(11,48) 1
Use of illicit drugs 0,294
No 388(97,73) 177(96,72) ,68(0,30-1,53)
Yes (user) 3(0,76) 2(1,09) 1
Yes (already used) 6(1,51) 4(2,19) 0,67(0,30-1,48)
Pronation 0,028
No 154(38,99) 60(32,97) 1
Yes 241(61,01) 122(67,03) 1,30(1,03-1,64)
Dexamethasone use 0,861
No 79(19,95) 37(20,33) 1
Yes 317(80,05) 145(79,67) 0,98(0,75-1,27)
Use of Azithromycin 0,005
Não 207(52,41) 81(44,75) 1
Sim 188(47,59) 100(55,25) 1,36(1,09-1,69)
Use of chloroquine or hydroxychloroquine 0,014
Não 390(98,73) 117(97,79) 0,57(0,36-0,89)
Sim 5(1,27) 4(2,21) 1
Use of Heparin (Enoxaparin) 0,074
Não 68(17,17) 24(13,19) 1
Sim 328(82,83) 158(86,81) 1,36(0,97-1,92)
CI: confidence interval; PR: adjusted prevalence ratio. The Wald test was used to calculate all “p” values, p < 0.05 was considered statistically significant (bold). Variables with p < 0.20 were later analyzed by multiple hierarchical Poisson regression. CI: confidence interval; PR: adjusted prevalence ratio. The Wald test was used to calculate all “p” values, p < 0.05 was considered statistically significant (bold). Variables with p < 0.20 were later analyzed by multiple hierarchical Poisson regression. CI: confidence interval; PR: adjusted prevalence ratio. The Wald test was used to calculate all “p” values, p < 0.05 was considered statistically significant (bold). Variables with p < 0.20 were later analyzed by multiple hierarchical Poisson regression. CI: confidence interval; PR: adjusted prevalence ratio. The Wald test was used to calculate all “p” values, p < 0.05 was considered statistically significant (bold). Variables with p < 0.20 were later analyzed by multiple hierarchical Poisson regression. CI: confidence interval; PR: adjusted prevalence ratio. The Wald test was used to calculate all “p” values, p < 0.05 was considered statistically significant (bold). Variables with p < 0.20 were later analyzed by multiple hierarchical Poisson regression.